Unicycive Therapeutics, Inc. — All Filings
264 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001346824-26-000059 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015349 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-001398 | Feb 10, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-006264 | Jan 23, 2026 | — |
| SCHEDULE 13G/A | — | 0001213900-25-111132 | Nov 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-111045 | Nov 14, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-111042 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016719 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112646 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001231919-25-000493 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001814554-25-000178 | Nov 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-108847 | Nov 12, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-108600 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-102790 | Oct 28, 2025 | — |
| 4 | — | 0001213900-25-080808 | Aug 26, 2025 | Aug 25, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-077937 | Aug 18, 2025 | Aug 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-077497 | Aug 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003536 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-078704 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-002285 | Aug 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-076066 | Aug 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-076007 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001214659-25-011857 | Aug 12, 2025 | — |
| 4 | — | 0001213900-25-069306 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069305 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069304 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069303 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069302 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069301 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | — | 0001213900-25-069300 | Jul 30, 2025 | Jul 28, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-061936 | Jul 8, 2025 | Jul 7, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-059303 | Jun 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-056188 | Jun 20, 2025 | Jun 17, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-054305 | Jun 13, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-052824 | Jun 10, 2025 | — |
| DEFA14A | CURRENT REPORT | 0001213900-25-052416 | Jun 9, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-052413 | Jun 9, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-046551 | May 22, 2025 | — |
| DEFA14A | CURRENT REPORT | 0001213900-25-046246 | May 21, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-046244 | May 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-013202 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-049529 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-043719 | May 15, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-042967 | May 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-042943 | May 14, 2025 | Mar 31, 2025 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-040661 | May 7, 2025 | — |
| ARS | ARS | 0001213900-25-037622 | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-037613 | Apr 30, 2025 | Jun 9, 2025 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-033307 | Apr 18, 2025 | — |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-25-031593 | Apr 14, 2025 | Mar 13, 2024 |